Home > Healthcare > Medical Devices > Diagnostic Devices > Wireless ECG Devices Market
Wireless ECG Devices Market size is poised for substantial growth between 2024 and 2032, driven by the notable advantages offered by these devices, such as compact size and seamless recording of heart rate and waveform. The versatility of wireless ECG machines in detecting various medical conditions, including arrhythmias, coronary heart diseases, heart attacks, and cardiomyopathy, is expected to further enhance market prospects in the coming years.
With the increasing heart attack rates, for instance, cardiovascular diseases account for nearly 17.9 million deaths each year as per the WHO, the demand for portable & reliable ECG devices will rise as well. This device assesses the rhythm and electrical activity of the heart, analyzing any abnormal heart rhythms. It can be employed alongside other tests to monitor symptoms indicative of potential heart issues, such as shortness of breath, dizziness, palpitations, and chest pain.
The increasing expenditure on cardiovascular diseases (CVDs) treatment is a significant factor driving trends in the wireless ECG devices industry. According to the European Heart Journal, the CVD annual cost across Europe is USD 306 billion. This, coupled with the growing adoption of remote patient monitoring technologies for enhanced care, presents additional progression opportunities for the market during the forecast period.
In terms of product, the stress ECG systems segment is expected to witness substantial gains through 2032. The expansion of this segment is attributed to the stress tests' ability to diagnose coronary heart diseases, identify heart rhythm issues, and guide the treatment of related disorders. The automation of various functions in wireless stress ECG tests allows patients to save time and boosts diagnostic confidence, contributing significantly to the product adoption in the years to come.
Middle East and Africa wireless ECG devices market is anticipated to hold a significant revenue share by 2032, driven by the rising prevalence of cardiovascular diseases as a contributor to morbidity and mortality, particularly in Saudi Arabia. The increased demand for healthcare services in the region is fueled by population growth, rapid urbanization, and the growing incidence of coronary problems and other chronic diseases. These factors, along with a strong emphasis on improving healthcare and living standards due to an aging population and advancements in medical science, will drive the adoption of wireless ECG monitoring systems across the MEA region.
Some of the major wireless ECG devices industry players include:
For instance, in April 2022, Nihon Kohden America, headquartered in Irvine, CA, USA, announced the extension of its Life Scope G Series by introducing the Life Scope G5 and G5Max to the U.S. market. This new series comprises bedside monitoring systems that incorporate advanced EGG parameter monitoring, including continuous QTc or QRSd, an advanced atrial fibrillation algorithm, improved review capabilities for ST analysis, and event recall.